We are live on ! Find out more
ICVX

Icosavax, Inc. Common Stock

Delisted

ICVX was delisted on the 16th of February, 2024.

93 hedge funds and large institutions have $664M invested in Icosavax, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 30 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

322% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 9

101% more capital invested

Capital invested by funds: $331M → $664M (+$333M)

100% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 15

45% more funds holding

Funds holding: 6493 (+29)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

88% less call options, than puts

Call options by funds: $830K | Put options by funds: $7.01M

Holders
93
Holders Change
+29
Holders Change %
+45.31%
% of All Funds
1.36%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
38
Increased
30
Reduced
15
Closed
9
Calls
$830K
Puts
$7.01M
Net Calls
-$6.18M
Net Calls Change
-$6.13M
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
26
UBS Group
Switzerland
$4.05M +$2.33M +242,325 +1,666%
GF
27
Gabelli Funds
New York
$4.01M +$2.45M +254,257 New
SCS
28
Syquant Capital SAS
France
$3M +$1.84M +190,654 New
AA
29
AQR Arbitrage
Connecticut
$3M +$1.83M +190,269 New
GCIA
30
Gabelli & Co Investment Advisers
New York
$2.63M +$1.61M +167,000 New
CL
31
CSS LLC
Illinois
$2.58M +$1.58M +163,879 New
Renaissance Technologies
32
Renaissance Technologies
New York
$2.38M +$1.46M +151,200 New
Morgan Stanley
33
Morgan Stanley
New York
$2.07M +$934K +97,021 +281%
Millennium Management
34
Millennium Management
New York
$1.84M +$1.12M +116,443 New
BFM
35
Boothbay Fund Management
New York
$1.66M +$1.02M +105,555 New
Tudor Investment Corp
36
Tudor Investment Corp
Connecticut
$1.58M +$963K +100,001 New
N
37
Nuveen
North Carolina
$1.56M +$94.8K +9,843 +11%
YCM
38
Yakira Capital Management
Connecticut
$1.55M +$944K +98,061 New
Bank of New York Mellon
39
Bank of New York Mellon
New York
$1.46M +$8.4K +872 +0.9%
Charles Schwab
40
Charles Schwab
California
$1.3M +$104K +10,783 +15%
HM
41
Harvest Management
New York
$1.25M +$761K +79,000 New
PAMP
42
Polar Asset Management Partners
Ontario, Canada
$1.18M +$722K +75,000 New
HighTower Advisors
43
HighTower Advisors
Illinois
$931K +$193 +20 +0%
Verition Fund Management
44
Verition Fund Management
Connecticut
$815K +$498K +51,693 New
TD Asset Management
45
TD Asset Management
Ontario, Canada
$680K -$135K -14,000 -25%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$670K +$17K +1,767 +4%
YIH
47
Y-Intercept (HK)
Hong Kong
$617K +$377K +39,135 New
GI
48
GAMCO Investors
Connecticut
$615K +$376K +38,994 New
Barclays
49
Barclays
United Kingdom
$595K -$1.58M -164,407 -81%
EPM
50
Equitec Proprietary Markets
Illinois
$567K +$347K +36,000 New

ICVX Hedge Fund Activity: Q4 2023 in Review

93 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Icosavax, Inc. Common Stock (ICVX) for Q4 2023, worth a combined $664M — up 101% from $331M a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new ICVX positions and 9 closed out — a net gain of 29 holders — while 30 added to existing stakes and 15 trimmed.

The largest buyer was Pentwater Capital Management, opening a new position worth an estimated $28.9M. The largest seller was Fidelity Investments, cutting an estimated $30.9M.

  • 93 institutional investors held Icosavax, Inc. Common Stock (ICVX) as of Q4 2023, up from 64 in Q3 2023.
  • Funds reported $664M of Icosavax, Inc. Common Stock stock for Q4 2023, up 101% quarter-over-quarter.
  • 38 funds opened new Icosavax, Inc. Common Stock positions in Q4 2023 and 9 closed out, a net change of +29 holders.
  • The largest Icosavax, Inc. Common Stock buyer in Q4 2023 was Pentwater Capital Management, an estimated $28.9M added.
  • The largest Icosavax, Inc. Common Stock seller in Q4 2023 was Fidelity Investments, an estimated $30.9M sold.

Based on aggregated 13F filings for Q4 2023.